Home > Insider Trading > Aratana Therapeutics Inc.

Aratana Therapeutics Inc. (PETX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Did Hedge Funds Drop The Ball On Aratana Therapeutics Inc (PETX)?

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...

Keep Reading →

June 28th, 2019 - Hedge Funds News

Do Hedge Funds Love Aratana Therapeutics Inc (PETX)?

Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies ...

Keep Reading →

December 23rd, 2018 - Hedge Funds News

13D Filing: Engaged Capital and Aratana Therapeutics Inc. (PETX)

Aratana Therapeutics Inc. (NASDAQ:PETX): Glenn W. Welling's Engaged Capital filed an amended 13D. You can check out Engaged Capital's latest holdings and filings here.

Keep Reading →

April 5th, 2018 - Hedge Funds

13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

May 11th, 2017 - Hedge Funds

Here Is What Hedge Funds Think About Aratana Therapeutics Inc (PETX)

Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant...

Keep Reading →

December 16th, 2016 - Hedge Funds News

Is Aratana Therapeutics Inc (PETX) A Good Stock To Buy?

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash...

Keep Reading →

December 13th, 2016 - Hedge Funds News

Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks' Prospects

March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks.

Keep Reading →

November 15th, 2016 - Hedge Funds News

Is Aratana Therapeutics Inc (PETX) A Worthy Healthcare Investment?

Is Aratana Therapeutics Inc (NASDAQ:PETX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it.

Keep Reading →

November 22nd, 2015 - Hedge Funds News

What Do Hedge Funds Have To Say About These 3 Purchases?

Most hedge funds and other money managers tracked by Insider Monkey have not submitted their 13F filings for the September quarter just yet.

Keep Reading →

November 4th, 2015 - Hedge Fund Analysis Hedge Funds News

Healthcare-Focused Investor Believes These Three Cheap Stocks are Poised to Explode

September was one of the worst periods for healthcare stocks and the returns of healthcare-focused investors suffered a lot amid an 11% drop in the NASDAQ Biotech ETF (IBB) and a 16% decline in the S...

Keep Reading →

November 3rd, 2015 - Hedge Funds News